- Home
- WLDS vs BLRX Comparison
WLDS vs BLRX Comparison
Compare WLDS & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- BLRX
- Stock Information
- Founded
- WLDS 2014
- BLRX 2003
- Country
- WLDS Israel
- BLRX Israel
- Employees
- WLDS N/A
- BLRX N/A
- Industry
- WLDS Computer Communications Equipment
- BLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- BLRX Health Care
- Exchange
- WLDS Nasdaq
- BLRX Nasdaq
- Market Cap
- WLDS 19.7M
- BLRX 17.1M
- IPO Year
- WLDS 2022
- BLRX 2011
- Fundamental
- Price
- WLDS $1.81
- BLRX $3.31
- Analyst Decision
- WLDS
- BLRX Strong Buy
- Analyst Count
- WLDS 0
- BLRX 2
- Target Price
- WLDS N/A
- BLRX $19.00
- AVG Volume (30 Days)
- WLDS 506.8K
- BLRX 23.4K
- Earning Date
- WLDS 12-09-2025
- BLRX 11-24-2025
- Dividend Yield
- WLDS N/A
- BLRX N/A
- EPS Growth
- WLDS N/A
- BLRX N/A
- EPS
- WLDS N/A
- BLRX N/A
- Revenue
- WLDS $422,000.00
- BLRX $17,251,000.00
- Revenue This Year
- WLDS N/A
- BLRX N/A
- Revenue Next Year
- WLDS N/A
- BLRX N/A
- P/E Ratio
- WLDS N/A
- BLRX N/A
- Revenue Growth
- WLDS N/A
- BLRX 1.19
- 52 Week Low
- WLDS $1.00
- BLRX $2.30
- 52 Week High
- WLDS $11.92
- BLRX $22.60
- Technical
- Relative Strength Index (RSI)
- WLDS 31.22
- BLRX 36.24
- Support Level
- WLDS $2.51
- BLRX $3.30
- Resistance Level
- WLDS $2.69
- BLRX $3.89
- Average True Range (ATR)
- WLDS 0.28
- BLRX 0.23
- MACD
- WLDS -0.08
- BLRX -0.04
- Stochastic Oscillator
- WLDS 2.13
- BLRX 26.58
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.